fatnews.com Home page  >  Article | Previous article | Next article



  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Hydroxychloroquine decreased mortality in critically-ill COVID-19 patients (19% vs 46%)

    Posted by .(JavaScript must be enabled to view this email address)
    Wednesday, May 06, 2020 4:07 pm Email this article

    Among 568 critically-ill patients treated in a similar manner, 45.8% of those not given hydroxychloroquine died (238/520) versus 18.8% of those given hydroxychloroquine (9/48) — 200 mg twice a day for 7-10 days — according to a retrospective study from China.

    The authors of the study concluded:

    “Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill patients with COVID-19…
    Therefore, hydroxychloroquine should be prescribed for treatment of critically ill COVID-19 patients to save lives.”

    Running Title: Hydroxychloroquine decreases COVID-19 mortality

    Corresponding Author’s Contact Info

    Dao Wen Wang, MD, PhD
    Division of Cardiology, Department of Internal Medicine
    Tongji Hospital, Tongji Medical College
    Huazhong University of Science and Technology
    1095 Jiefang Ave., Wuhan 430030, China
    Tel./Fax 86-27-8366-2843
    .(JavaScript must be enabled to view this email address)

    The study is posted here:



    Articles on the same subject can be found here:


    Please feel free to share your comments about this article.




    Please enter the word you see in the image below:

    Remember my personal information

    Notify me of follow-up comments?

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.